President and CEO of Toronto's Baycrest & Centre for Aging + Brain Health Innovation appointed to federal Ministerial Advisory Board on Dementia

Monday, May 14, 2018 Mental Health News
Email Print This Page Comment bookmark
Font : A-A+

TORONTO, May 14, 2018 /CNW/ - Baycrest and the Centre for Aging + Brain Health Innovation (CABHI) are pleased to announce

that its President and Chief Executive Officer, Dr. William E. Reichman, has recently been appointed co-chair of the newly established Ministerial Advisory Board on Dementia, by the federal government.

The Honourable

Ginette Petitpas Taylor, federal Minister of Health, announced today at the National Dementia Conference in Ottawa, the establishment of a Ministerial Advisory Board to advise her on matters related to the health of persons living with dementia. The Board, which will be co-chaired by Dr. Reichman, and Pauline Tardif, Chief Executive Officer of the Alzheimer Society of Canada, will represent people living with dementia, their caregivers, researchers, advocacy groups, and health care professionals.

The National Dementia Conference, taking place May 14 – 15, is bringing together a broad range of stakeholder groups and partners from across the country to help inform a national dementia strategy.

"I am honoured to join the Ministerial Advisory Board on Dementia as its co-chair and work together with the Alzheimer's Society of Canada and other members," said Dr. Reichman.  "The increasing prevalence of dementia is one of the greatest public health challenges of our time. This strategy presents an opportunity to integrate the shared perspectives of all stakeholders impacted by dementia, and to build on the innovation assets we have across the country. Together, we must ensure that key supports will be in place to address the needs of the aging population. The federal government's commitment to developing a national dementia strategy is a great step forward for all Canadians today, for generations to come."

The National Dementia Conference and the establishment of the Ministerial Advisory Board on Dementia fulfills two key components of the National Strategy for Alzheimer's Disease and Other Dementias Act.

Dr. Reichman, an internationally-known expert in geriatric mental health and dementia care, is President and Chief Executive Officer of Baycrest, one of the world's premier academic health sciences centres focused on aging, seniors care and brain function and home to the Centre for Aging + Brain Health Innovation. Baycrest also recently announced it will become Headquarters and Research Network Centre for the Canadian Consortium on Neurodegeneration in Aging, the premier research hub for all aspects of research involving neurodegenerative diseases that affect cognition in aging – including Alzheimer's disease.

Dr. Reichman is also Professor of Psychiatry on the Faculty of Medicine at the University of Toronto, former president of the American Association for Geriatric Psychiatry and the Geriatric Mental Health Foundation and is President-elect of the International Psychogeriatric Association. He has advised several levels of government in the United States, Canada and China on the impact of an aging society on health care demand and the mandate to support innovative approaches to service delivery.

Dr. Reichman was the founder and inaugural Chair of the Seniors Quality Leap Initiative, a collaborative of prominent eldercare organizations and their affiliated universities in the United States and Canada working together to advance the effectiveness of long-term care across the globe.

About Baycrest Now in its 100th year, Baycrest is a global leader in geriatric residential living, healthcare, research, innovation and education, with a special focus on brain health and aging. Fully affiliated with the University of Toronto, Baycrest provides excellent care for older adults combined with an extensive clinical training program for the next generation of healthcare professionals and one of the world's top research institutes in cognitive neuroscience, the Rotman Research Institute. Baycrest is home to the federally and provincially-funded Canadian Centre for Aging + Brain Health Innovation, a solution accelerator focused on driving innovation in the aging and brain health sector, and is the developer of Cogniciti – a free online memory assessment for Canadians 40+ who are concerned about their memory.  Founded in 1918 as the Jewish Home for Aged, Baycrest continues to embrace the long-standing tradition of all great Jewish healthcare institutions to improve the well-being of people in their local communities and around the globe. For more information please visit: www.baycrest.org

The Centre for Aging + Brain Health Innovation (CABHI) is a solution accelerator for the aging and brain health sector, providing funding and support to innovators for the development, testing, and dissemination of new ideas and technologies that address unmet brain health and seniors' care needs. Established in 2015, it is the result of the largest investment in brain health and aging in Canadian history. CABHI is a unique collaboration of health care, science, industry, not-for-profit and government partners whose aim is to help improve quality of life for the world's aging population, allowing older adults to age safely in the setting of their choice while maintaining their cognitive, emotional, and physical well-being. For more information on CABHI, please visit: www.cabhi.com.

SOURCE Baycrest Centre for Geriatric Care

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store